Fredersdorf S, Milne A W, Hall P A, Lu X
Ludwig Institute for Cancer Research, St. Mary's Hospital Medical School, London, United Kingdom.
Am J Pathol. 1996 Mar;148(3):825-35.
As a universal inhibitor of cyclin-dependent kinases and one of the target genes of the tumor suppresser p53, p21Waf1/Cip1 can act as a tumor suppresser through its ability to control cell cycle progression. To study the function of p21Waf1/Cip1 protein and to investigate its tissue distribution, a panel of anti-p21Waf1/Cip1 monoclonal antibodies was generated. These anti-p21Waf1/Cip1 monoclonal antibodies were initially raised against a GST-p21Waf1/Cip1 fusion protein produced in bacteria. Detailed characterization of the antibodies showed that they can specifically detect p21Waf1/Cip1 by immunoblotting, immunoprecipitation, and immunostaining. The specific induction of p21Waf1/Cip1 expression in response to gamma-radiation in cells containing p53 was also detected by these antibodies. The ability to detect p21Waf1/Cip1 expression in conventionally fixed tissue sections allowed us to investigate the distribution of p21Waf1/Cip1 in 23 different types of normal human tissues, and p21Waf1/Cip1 expression was found in most tissues. A close inverse relationship between p21Waf1/Cip1 expression and proliferation was seen in some tissues, including gastrointestinal tract. However, such association is not universal. In tissues such as lung, kidney, thyroid, pancreatic ducts and acini, and liver, despite the fact that most of the cells are quiescent, expression of p21Waf1/Cip1 was detected only in occasional epithelial cells. All these suggest that the expression of p21Waf1/Cip1 varies among different human tissues. Finally, epitope mapping of the anti-p21Waf1/Cip1 antibodies using a peptide library covering the entire p21Waf1/Cip1 protein sequence indicates that two of the antibodies recognize a region of p21Waf1/Cip1 close to that bound by proliferating cell nuclear antigen. These two monoclonal antibodies will therefore be additionally useful in further understanding the functions of p21Waf1/Cip1 both in vitro and in vivo.
作为细胞周期蛋白依赖性激酶的通用抑制剂以及肿瘤抑制因子p53的靶基因之一,p21Waf1/Cip1能够通过控制细胞周期进程发挥肿瘤抑制作用。为了研究p21Waf1/Cip1蛋白的功能并探究其组织分布,我们制备了一组抗p21Waf1/Cip1单克隆抗体。这些抗p21Waf1/Cip1单克隆抗体最初是针对细菌中产生的GST-p21Waf1/Cip1融合蛋白制备的。对这些抗体的详细表征表明,它们能够通过免疫印迹、免疫沉淀和免疫染色特异性检测p21Waf1/Cip1。这些抗体还检测到了含p53细胞中γ射线诱导的p21Waf1/Cip1表达的特异性上调。能够在常规固定的组织切片中检测p21Waf1/Cip1表达,使我们得以研究p21Waf1/Cip1在23种不同类型正常人组织中的分布,结果发现大多数组织中都有p21Waf1/Cip1表达。在包括胃肠道在内的一些组织中,观察到p21Waf1/Cip1表达与增殖之间存在密切的负相关关系。然而,这种关联并不普遍。在肺、肾、甲状腺、胰管和腺泡以及肝脏等组织中,尽管大多数细胞处于静止状态,但仅在偶尔的上皮细胞中检测到p21Waf1/Cip1表达。所有这些都表明p21Waf1/Cip1在不同人体组织中的表达存在差异。最后,使用覆盖整个p21Waf1/Cip1蛋白序列的肽库对抗p21Waf1/Cip1抗体进行表位作图表明,其中两种抗体识别的p21Waf1/Cip1区域靠近增殖细胞核抗原结合的区域。因此,这两种单克隆抗体在进一步理解p21Waf1/Cip1在体内外的功能方面将具有额外的用途。